Citations

Showing 10 of 108036 citations.

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer
Wu, Changping , Jin, Xin , Yang, Yinhui , He, Yundong , Ding, Liya , Pan, Yunqian , Yang, H. J. , Chen, Shuai , Jiang, Jingting , Huang, Haojie , Jin, Xin

Mayo Clinic

Oncotarget | December 9, 2015 | Volume: 7 | Issue: 3 | Pages: 3440-3452

10.18632/oncotarget.6497 | PMID 26657505 Get It

The impact of a spiritual legacy intervention in patients with brain cancers and other neurologic illnesses and their support persons
Piderman, Katherine M. , Breitkopf, Carmen Radecki , Jenkins, Sarah M. , Kwete, Gracia M., Sytsma, Terin T. , Lovejoy, Laura A., Yoder, Timothy J., Jatoi, Aminah , Radecki Breitkopf, Carmen, Lapid, Maria I.

Mayo Clinic

Psycho-Oncology | December 9, 2015 | Volume: 26 | Issue: 3 | Pages: 346-353

10.1002/pon.4031 | PMID 26643586 Get It

AbstractObjectiveThe objectives were to assess the feasibility of using a novel, comprehensive chaplain‐led spiritual life review interview to develop a personal Spiritual Legacy Document (SLD) for persons with brain tumors and other neurodegenerative diseases and to describe spiritual well‐being (SWB), spiritual coping, and quality of life (QOL) of patients and their support persons (SP) before and after receipt of the SLD.MethodsPatient‐SP pairs were enrolled over a 2‐year period. Assessments included the Functional Assessment of Chronic Illness Therapy‐Spiritual Expanded Version, Brief Religious Coping Scale, Brief COPE Inventory, and QOL Linear Analog Scale. Baseline assessments were completed prior to an audio‐recorded spiritual life review interview with a chaplain.ResultsThirty‐two patient/SP pairs were enrolled; 27 completed baseline assessments and the interview. Twenty‐four reviewed their SLD and were eligible for follow‐up. A total of 15 patients and 12 SPs completed the 1‐month follow‐up; 10 patients and seven SPs completed the 3‐month follow‐up. Patients endorsed high levels of SWB and spiritual coping at baseline. Both patients and SPs evidenced improvement on several aspects of SWB, spiritual coping, and QOL at 1 month, but patients' decreased financial well‐being was also observed. Patients and SPs demonstrated favorable changes in peacefulness and positive religious coping at both time points.ConclusionsA chaplain‐led spiritual life review is a feasible intervention for patients with neurodegenerative disease and results in beneficial effects on patients and SPs. Copyright © 2015 John Wiley & Sons, Ltd.
Small Sample Kernel Association Tests for Human Genetic and Microbiome Association Studies
Chen, Wenan , Wu, Michael C. , Schaid, Daniel J. , Chen, Jun , Zhao, Ni , Wu, Michael C

Mayo Clinic

Genetic Epidemiology | December 9, 2015 | Volume: 40 | Issue: 1 | Pages: 5-19

10.1002/gepi.21934 | PMID 26643881 Get It

AbstractKernel machine based association tests (KAT) have been increasingly used in testing the association between an outcome and a set of biological measurements due to its power to combine multiple weak signals of complex relationship with the outcome through the specification of a relevant kernel. Human genetic and microbiome association studies are two important applications of KAT. However, the classic KAT framework relies on large sample theory, and conservativeness has been observed for small sample studies, especially for microbiome association studies. The common approach for addressing the small sample problem relies on computationally intensive resampling methods. Here, we derive an exact test for KAT with continuous traits, which resolve the small sample conservatism of KAT without the need for resampling. The exact test has significantly improved power to detect association for microbiome studies. For binary traits, we propose a similar approximate test, and we show that the approximate test is very powerful for a wide range of kernels including common variant‐ and microbiome‐based kernels, and the approximate test controls the type I error well for these kernels. In contrast, the sequence kernel association tests have slightly inflated genomic inflation factors after small sample adjustment. Extensive simulations and application to a real microbiome association study are used to demonstrate the utility of our method.
The Triumph of Innovation and the Hard Work of Caring for Patients With Diabetes
Montori, Víctor M. , Rodríguez‐Gutiérrez, René , Montori, Victor M

Mayo Clinic

Annals of Internal Medicine | December 9, 2015 | Volume: 164 | Issue: 2 | Pages: 127-128

10.7326/m15-2610 | PMID 26641027 Get It

Biopsy Proven Hepatic Segmental Arteriolar Mediolysis Successfully Treated With Coil Embolization
Ashfaq, Awais , Money, Samuel R.

Mayo Clinic

Circulation | December 8, 2015 | Volume: 132 | Issue: 23 | Pages: 2265-2266

10.1161/circulationaha.115.016228 | PMID 26644249 Get It

Leukemia cutis imitating venous ulcerations
Little, Yvonne, McBane, Robert D. , Wysokiński, Waldemar E. , McBane, Robert

Mayo Clinic

Vascular Medicine | December 8, 2015 | Volume: 21 | Issue: 2 | Pages: 172-173

10.1177/1358863x15621168 | PMID 26644375 Get It

Expanding Phenotypic Spectrum ofNKX2-1–Related Disorders—Mitochondrial and Immunologic Dysfunction
Ahlskog, J. Eric , Patterson, Marc C. , Milone, Margherita , Coon, Elizabeth A. , Niu, Zhiyv , Patterson, Marc

Mayo Clinic

JAMA Neurology | December 8, 2015 | Volume: 73 | Issue: 2 | Pages: 237

10.1001/jamaneurol.2015.2976 | PMID 26640963 Get It

Treatment Planning Studies in Patient Data With Scanned Carbon Ion Beams for Catheter‐Free Ablation of Atrial Fibrillation
Constantinescu, A., Packer, Douglas L. , Bert, Christoph , Durante, Marco , Graeff, Christian , Lehmann, H. Immo , Bert, Christoph , Durante, Marco , Graeff, Christian

Mayo Clinic

Journal of Cardiovascular Electrophysiology | December 8, 2015 | Volume: 27 | Issue: 3 | Pages: 335-344

10.1111/jce.12888 | PMID 26638826 Get It

Noninvasive AF Ablation With Carbon IonsIntroductionCatheter ablation with isolation of the pulmonary veins is a common treatment option for atrial fibrillation but still has insufficient success rates and carries several interventional risks. These treatment planning studies assessed if high‐dose single fraction treatment with scanned carbon ions (12C) can be reliably delivered for AF ablation, while sparing risk structures and considering respiratory and contractile target motion.Methods and ResultsTime resolved CT scans of complete respiratory and cardiac cycles of 9 and 5 patients, respectively, were obtained. Ablation lesions and organs at risk for beam delivery were contoured. Single fraction intensity‐modulated particle therapy with target doses of 25 and 40 Gy were studied and motion influences on these deliveries mitigated. Respiration had a large influence on lesion displacement (≤ 2 cm). End expiration could be exploited as a stable gating window. Smaller, but less predictable, heartbeat displacements (< 6 mm) remained to be mitigated because cardiac contraction resulted in insufficient dose coverage (V95 < 90 %) if uncompensated. Repeated irradiation (12C beam rescanning) during breath hold was used to accommodate contractile motion, resulting in good dose coverage. Dose depositions to all organs at risk were carefully examined and did not exceed values for X‐ray cancer treatment.ConclusionTreatment planning of 12C with delivery of physical ionizing radiation doses that have been described to induce complete block is feasible for AF ablation, considering human anatomy, dose constraints, and encasing underlying motion patterns from respiration and cardiac contraction at the LA–PV junction into treatment planning.
Modeling X Chromosome Data Using Random Forests: Conquering Sex Bias
Winham, Stacey J. , Jenkins, Gregory D. , Biernacka, Joanna M. , Winham, Stacey J

Mayo Clinic

Genetic Epidemiology | December 8, 2015 | Volume: 40 | Issue: 2 | Pages: 123-132

10.1002/gepi.21946 | PMID 26639183 Get It

Is It Finally Time for a Personalized Medicine Approach for Fluorouracil-Based Therapies?
Offer, Steven M. , Diasio, Robert B. , Offer, Steven M

Mayo Clinic

Journal of Clinical Oncology | December 8, 2015 | Volume: 34 | Issue: 3 | Pages: 205-207

10.1200/jco.2015.64.2546 | PMID 26644533 Get It